Welcome to our dedicated page for Senestech news (Ticker: SNES), a resource for investors and traders seeking the latest updates and insights on Senestech stock.
SenesTech, Inc. (NASDAQ: SNES) generates news as a biotechnology company focused on fertility control for rodent management. Its announcements frequently highlight developments related to ContraPest®, Evolve Rat, and Evolve Mouse Birth Control, which are described as contraceptive products for rats and mice that fit into integrated pest management programs and reduce reliance on traditional rodenticides.
Investors and observers following SNES news will see regular updates on financial performance and growth in Evolve rodent birth control products. Quarterly press releases report record revenues, gross profit margins, and the share of revenue contributed by Evolve-branded products, as well as commentary on adjusted EBITDA and cash balances. These releases often discuss progress toward profitability and the impact of multi-channel distribution strategies.
Company news also covers operational and commercial milestones. Examples include the launch of Evolve Rat Birth Control on major e-commerce platforms and home improvement retailer websites, expanded retail coverage through partners and wholesalers, and municipal pilot deployments in U.S. cities. Additional updates describe international distribution relationships, such as the appointment of the Belize Raptor Center as an official distributor following regulatory approval in Belize.
Regulatory and capital markets activities appear in SenesTech’s news flow as well. The company issues press releases on warrant exercises, gross proceeds from financings, and participation in investor conferences. For readers tracking SNES, this news page offers a way to monitor how SenesTech reports on product adoption, distribution channels, municipal and community programs, and financing events over time.
SenesTech, Inc. (NASDAQ: SNES) will participate in the Lytham Partners Virtual Investor Growth Conference on October 7, 2020, at 12:00pm ET. The conference will feature a presentation and fireside chat, followed by virtual one-on-one meetings with management. SenesTech focuses on innovative pest management through its product, ContraPest®, aimed at controlling rat populations non-lethally. The webcast will be available on SenesTech's investor relations website, with a replay accessible post-event.
SenesTech, Inc. (NASDAQ: SNES) announced that California's AB1788 has passed the Legislature and is awaiting the Governor's signature. This bill aims to restrict the use of Second Generation Anticoagulant Rodenticides, impacting pest management strategies. SenesTech's fertility control product, ContraPest®, is highlighted as an effective alternative in integrated pest management (IPM) programs across diverse environments, positioning the company favorably amid regulatory changes. The team emphasizes collaboration with pest management professionals to adapt to this evolving landscape.
SenesTech, Inc. (NASDAQ: SNES) reported its second-quarter fiscal 2020 results, highlighting significant revenue growth, reaching approximately $71,000 compared to $24,000 in Q2 2019. The company made strides in pilot programs for municipal and poultry industries and created a direct-to-consumer online platform. Despite a net loss of $(1.6) million, an improvement from $(2.3) million in the prior year, operational projects continued amid COVID-19 challenges. Key partnerships, including deployment of ContraPest in Washington D.C., were confirmed for wider application as budgets permit.
On August 12, 2020, SenesTech, Inc. (NASDAQ: SNES) announced the San Francisco Recreation and Parks Department's success using its fertility control product, ContraPest, which was integrated into their pest management strategies in 2019. The program has reportedly led to a 65% reduction in burrow counts, showcasing a significant impact on rodent populations without harming the environment. ContraPest targets reproduction in both male and female rats, promoting an eco-friendly alternative to traditional rodenticides.
SenesTech, Inc. (NASDAQ: SNES) will announce its second quarter 2020 financial results after the market closes on August 12, 2020. A conference call is scheduled for the same day at 5:00 pm ET to discuss these results. The company focuses on innovative pest management with its product ContraPest®, which targets rat reproduction. This technology aims to reduce reliance on lethal pest control methods.